Towa Pharmaceutical Co., Ltd. (4553.T)
JPY 2618.0
(0.81%)
JPY 2618.0
(0.81%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 81.38 Billion JPY | 11.92% |
| 2022 | 72.71 Billion JPY | 3.6% |
| 2021 | 70.18 Billion JPY | 7.23% |
| 2020 | 65.45 Billion JPY | 29.23% |
| 2019 | 50.64 Billion JPY | 4.64% |
| 2018 | 48.39 Billion JPY | 12.42% |
| 2017 | 43.05 Billion JPY | 10.25% |
| 2016 | 39.04 Billion JPY | -6.71% |
| 2015 | 41.85 Billion JPY | 13.17% |
| 2014 | 36.98 Billion JPY | 22.34% |
| 2013 | 30.23 Billion JPY | 8.97% |
| 2012 | 27.74 Billion JPY | 3.77% |
| 2011 | 26.73 Billion JPY | 7.81% |
| 2010 | 24.79 Billion JPY | 22.46% |
| 2009 | 20.24 Billion JPY | 14.92% |
| 2008 | 17.62 Billion JPY | 17.66% |
| 2007 | 14.97 Billion JPY | 9.75% |
| 2006 | 13.64 Billion JPY | 24.54% |
| 2005 | 10.95 Billion JPY | -1.62% |
| 2004 | 11.13 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 23.34 Billion JPY | 11.29% |
| 2023 Q1 | 20 Billion JPY | -7.63% |
| 2023 FY | 81.38 Billion JPY | 11.92% |
| 2023 Q4 | 20.97 Billion JPY | -5.39% |
| 2023 Q3 | 22.16 Billion JPY | 21.59% |
| 2023 Q2 | 18.23 Billion JPY | -8.88% |
| 2022 FY | 72.71 Billion JPY | 3.6% |
| 2022 Q4 | 21.66 Billion JPY | 21.17% |
| 2022 Q2 | 16.5 Billion JPY | -0.95% |
| 2022 Q1 | 16.66 Billion JPY | 1.5% |
| 2022 Q3 | 17.87 Billion JPY | 8.29% |
| 2021 Q4 | 16.42 Billion JPY | -10.7% |
| 2021 Q2 | 17.13 Billion JPY | -6.13% |
| 2021 Q3 | 18.38 Billion JPY | 7.34% |
| 2021 Q1 | 18.24 Billion JPY | 5.08% |
| 2021 FY | 70.18 Billion JPY | 7.23% |
| 2020 Q2 | 15.43 Billion JPY | -2.94% |
| 2020 Q1 | 15.89 Billion JPY | 37.74% |
| 2020 FY | 65.45 Billion JPY | 29.23% |
| 2020 Q4 | 17.36 Billion JPY | 3.61% |
| 2020 Q3 | 16.76 Billion JPY | 8.62% |
| 2019 Q1 | 13.3 Billion JPY | 6.91% |
| 2019 Q3 | 12.97 Billion JPY | 1.14% |
| 2019 Q2 | 12.82 Billion JPY | -3.61% |
| 2019 FY | 50.64 Billion JPY | 4.64% |
| 2019 Q4 | 11.54 Billion JPY | -11.03% |
| 2018 Q1 | 11.6 Billion JPY | 13.63% |
| 2018 Q2 | 10.39 Billion JPY | -10.4% |
| 2018 FY | 48.39 Billion JPY | 12.42% |
| 2018 Q4 | 12.44 Billion JPY | -10.83% |
| 2018 Q3 | 13.95 Billion JPY | 34.29% |
| 2017 Q1 | 9.96 Billion JPY | 4.27% |
| 2017 Q4 | 10.2 Billion JPY | -14.38% |
| 2017 FY | 43.05 Billion JPY | 10.25% |
| 2017 Q3 | 11.92 Billion JPY | 8.85% |
| 2017 Q2 | 10.95 Billion JPY | 9.92% |
| 2016 Q3 | 10.8 Billion JPY | 12.38% |
| 2016 Q2 | 9.61 Billion JPY | 5.94% |
| 2016 FY | 39.04 Billion JPY | -6.71% |
| 2016 Q1 | 9.07 Billion JPY | -16.28% |
| 2016 Q4 | 9.55 Billion JPY | -11.53% |
| 2015 Q3 | 11.1 Billion JPY | 10.04% |
| 2015 Q1 | 9.81 Billion JPY | 1.22% |
| 2015 FY | 41.85 Billion JPY | 13.17% |
| 2015 Q4 | 10.83 Billion JPY | -2.4% |
| 2015 Q2 | 10.09 Billion JPY | 2.78% |
| 2014 Q1 | 8.17 Billion JPY | 11.85% |
| 2014 FY | 36.98 Billion JPY | 22.34% |
| 2014 Q4 | 9.7 Billion JPY | -10.9% |
| 2014 Q3 | 10.88 Billion JPY | 32.51% |
| 2014 Q2 | 8.21 Billion JPY | 0.49% |
| 2013 Q4 | 7.31 Billion JPY | -17.28% |
| 2013 FY | 30.23 Billion JPY | 8.97% |
| 2013 Q1 | 6.86 Billion JPY | 11.27% |
| 2013 Q2 | 7.21 Billion JPY | 5.14% |
| 2013 Q3 | 8.83 Billion JPY | 22.46% |
| 2012 Q1 | 7.19 Billion JPY | 6.17% |
| 2012 Q2 | 6.79 Billion JPY | -5.54% |
| 2012 FY | 27.74 Billion JPY | 3.77% |
| 2012 Q3 | 7.57 Billion JPY | 11.46% |
| 2012 Q4 | 6.16 Billion JPY | -18.58% |
| 2011 Q2 | 6.19 Billion JPY | -4.15% |
| 2011 Q1 | 6.45 Billion JPY | -2.81% |
| 2011 Q3 | 7.3 Billion JPY | 18.03% |
| 2011 Q4 | 6.77 Billion JPY | -7.21% |
| 2011 FY | 26.73 Billion JPY | 7.81% |
| 2010 Q4 | 6.64 Billion JPY | 0.74% |
| 2010 Q2 | 6.06 Billion JPY | 10.45% |
| 2010 Q1 | 5.49 Billion JPY | 7.18% |
| 2010 FY | 24.79 Billion JPY | 22.46% |
| 2010 Q3 | 6.59 Billion JPY | 8.76% |
| 2009 Q3 | 5.34 Billion JPY | 6.79% |
| 2009 FY | 20.24 Billion JPY | 14.92% |
| 2009 Q1 | 4.77 Billion JPY | 0.61% |
| 2009 Q4 | 5.12 Billion JPY | -4.21% |
| 2009 Q2 | 5 Billion JPY | 4.97% |
| 2008 Q4 | 4.74 Billion JPY | 2.72% |
| 2008 Q1 | 3.97 Billion JPY | 0.0% |
| 2008 FY | 17.62 Billion JPY | 17.66% |
| 2008 Q3 | 4.61 Billion JPY | 7.59% |
| 2008 Q2 | 4.29 Billion JPY | 7.99% |
| 2007 FY | 14.97 Billion JPY | 9.75% |
| 2006 FY | 13.64 Billion JPY | 24.54% |
| 2005 FY | 10.95 Billion JPY | -1.62% |
| 2004 FY | 11.13 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | -66.933% |
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 96.275% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 56.707% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | 77.95% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -2198.404% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | 16.115% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | -112.922% |
| Eisai Co., Ltd. | 586.41 Billion JPY | 86.122% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -1256.836% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | -3.054% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | -56.295% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | -502.079% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -951.732% |
| Tsumura & Co. | 68.81 Billion JPY | -18.26% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | -117.945% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | -228.263% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | -392.782% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | -62.178% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | -58.333% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -7442.447% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -727.147% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -1744.995% |
| MedRx Co., Ltd | 26 Million JPY | -312911.538% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -914.028% |
| Solasia Pharma K.K. | 337 Million JPY | -24049.258% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 11133205.335% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | -165.394% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | -49.824% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -215518.376% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | 27.97% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -1125.721% |